Catalyst Wire Dossier Catalyst Wire Dossier

Aspirin and extended-release dipyridamole

Aspirin and extended-release dipyridamole · AvKARE
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Aspirin and extended-release dipyridamole, covering 2016-03-08 to 2025-07-29. Get the full timeline:

Most recent: FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (AvKARE)

See pricing